List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 17 studies with search of:   Open Studies | Belarus
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of LJP 394 in Lupus Patients With History of Renal Disease
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: abetimus sodium (LJP 394) and/or placebo solution;   Drug: abetimus sodium (LJP 394);   Drug: Phosphate-buffered saline
2 Recruiting LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non-Small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIBF 1120;   Drug: placebo;   Drug: docetaxel
3 Recruiting Study of ACT-064992 on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-064992;   Drug: ACT-064992;   Drug: Placebo
4 Recruiting Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 mg;   Drug: Placebo
5 Recruiting Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
6 Recruiting Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment
Condition: Type 2 Diabetes
Interventions: Drug: Saxagliptin;   Drug: Placebo
7 Recruiting Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: BG00012
8 Recruiting Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder
Condition: Urinary Bladder, Overactive
Interventions: Drug: YM178;   Drug: Tolterodine 4 ng
9 Recruiting A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL)
Condition: Lymphoma, Non-Hodgkin's
Interventions: Drug: Galiximab in combination with rituximab;   Drug: Rituximab in combination with placebo
10 Recruiting A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older
Condition: Newly Diagnosed Multiple Myeloma
Intervention: Drug: Lenalidomide
11 Not yet recruiting Genes Causing Ebstein's Anomaly
Conditions: Heart Septal Defects, Ventricle;   Heart Defects, Congenital;   Double Outlet Right Ventricle;   Truncus Arteriosus, Persistent
Intervention:
12 Recruiting Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: SSR126517E "biotinylated idraparinux";   Drug: warfarin
13 Recruiting Clinical Study Assessing SSR126517E Injections Once-Weekly in Pulmonary Embolism Therapeutic Approach
Conditions: Embolism;   Thrombosis
Interventions: Drug: SSR126517E;   Drug: warfarin
14 Recruiting Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Interventions: Drug: C2L-OCT-01 PR, 10 or 20 mg;   Drug: C2L-OCT-01 PR, 20 mg
15 Recruiting Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions
Condition: Peripheral Vascular Diseases
Interventions: Drug: XRP0038/NV1FGF;   Drug: placebo
16 Recruiting Open Label Extension Study Evaluating Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients
Condition: Acromegaly
Intervention: Drug: C2L-OCT-01 PR 30 mg
17 Recruiting International Cooperation for Post-Cherynobyl NIS Thyroid Tissue and Data Banks
Condition: Environment
Intervention:

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services